CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK

2009 ◽  
Vol 145 (4) ◽  
pp. 491-499 ◽  
Author(s):  
Julius G. Juarez ◽  
Marilyn Thien ◽  
Aileen Dela Pena ◽  
Rana Baraz ◽  
Kenneth F. Bradstock ◽  
...  
Healthcare ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 531
Author(s):  
Wei-Ping Chen ◽  
Wen-Fang Chiang ◽  
Hung-Ming Chen ◽  
Jenq-Shyong Chan ◽  
Po-Jen Hsiao

Acute lymphoblastic leukaemia (ALL) is diagnosed by the presence of at least 30% lymphoblasts in the bone marrow or 20% lymphoblasts in peripheral blood. ALL may be aggressive and include the lymph nodes, liver, spleen, central nervous system (CNS), and other organs. Without early recognition and timely treatment, ALL will progress quickly and may have poor prognosis in clinical scenarios. ALL is a rare type of leukaemia in adults but is the most common type in children. Precipitating factors such as environmental radiation or chemical exposure, viral infection, and genetic factors can be associated with ALL. We report a rare case of ALL with symptomatic hypercalcaemia in an adult woman. The patient presented with general weakness, poor appetite, bilateral lower limbs oedema, consciousness disturbance, and lower back pain for 3 weeks. She had a history of cervical cancer and had undergone total hysterectomy, chemotherapy, and radiation therapy. Her serum calcium level was markedly increased, at 14.1 mg/dl at admission. Neck magnetic resonance imaging, abdominal sonography, abdominal computed tomography, and bone marrow examination were performed. Laboratory data, including intact parathyroid hormone (i-PTH), peripheral blood smear, and 25-(OH) D3, were checked. Bone marrow biopsy showed B cell lymphoblastic leukaemia. Chemotherapy was initiated to be administered but was discontinued due to severe sepsis. Finally, the patient died due to septic shock. This was a rare case of B cell ALL in an adult complicated by hypercalcaemic crisis, which could be a life-threatening emergency in clinical practice. Physicians should pay attention to the associated risk factors. Early recognition and appropriate treatment may improve clinical outcomes.


2017 ◽  
Vol 178 (2) ◽  
pp. 267-278 ◽  
Author(s):  
Prisca M. J. Theunissen ◽  
Anouk van den Branden ◽  
Alita Van Der Sluijs-Gelling ◽  
Valerie De Haas ◽  
Auke Beishuizen ◽  
...  

2019 ◽  
Vol 12 (2) ◽  
pp. e227400
Author(s):  
Yunzu Michele Wang ◽  
Jun Qin Mo ◽  
Dennis John Kuo ◽  
Victor Wong

We describe an unusual case of pre-B lymphoblastic leukaemia presenting with a unilateral maxillary sinus mass in which biopsies of the primary mass and the bone marrow demonstrated conflicting immunophenotyping results. The extramedullary mass was consistent with a precursor B-cell malignancy, while the bone marrow was initially reported as a possible mature B-cell malignancy. The treatments for the two are fundamentally different, which necessitated a delay in the initiation of his chemotherapy until a clear diagnosis was made. Mixed lineage leukaemia gene rearrangement was confirmed by fluorescence in situ hybridisation in both the primary mass and bone marrow, which unified the diagnosis as pre-B acute lymphoblastic leukaemia given the common cytogenetic feature.


Sign in / Sign up

Export Citation Format

Share Document